Atlas Trials

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Clinical trial NCT04662723 · RECRUITING

Trial details

NCT number
NCT04662723
Sponsor
Fondazione Schena
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
GlomerulonephritisImmunoglobulin A Nephropathy
Start date
2023-05-01
Primary completion
2026-06-01
Enrollment
878

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.